For citations:
Zamyatin A.V., Mager V.O., Orlov A.S., Il'in K.A., Zavatskiy S.E., Kovalenko D.A., Shcheglova V.P., Berzin S.A., Zyryanov A.V. Adjuvant intravesical chemotherapy with titanium glycerosolvate aquacomplex versus BCG therapy in patients with high risk nonmuscle-invasive bladder cancer. Cancer Urology. 2020;16(3):126-134. https://doi.org/10.17650/1726-9776-2020-16-3-126-134
Email this article 